Licensing and Alliances- Strategic Tools for Biotechs
All too often biotechs see alliances and collaborations as necessary evils - to be deferred and minimized wherever possible. Our view is different. We see collaborations as a central component of any successful, sustainable biotech strategy, because we believe that:
- Fundamental forces are increasing both the volume and ambition of collaborations.
- Well-executed collaborations have huge potential to create value (although poorly structured or timed deals and badly managed relationships can be highly destructive).
- In the future, a deal-by-deal approach is not going to be enough. Companies will have to be proactive in designing their network of alliances and build skills in managing and incentivizing these multiple relationships.
Read the full analysis:
For further information, contact
